These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 12083328

  • 1. Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBEAG-minus mutant.
    Husa P, Chalupa P, Stroblová H, Husová L, Slesinger P.
    Acta Virol; 2001; 45(5-6):293-7. PubMed ID: 12083328
    [Abstract] [Full Text] [Related]

  • 2. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [Abstract] [Full Text] [Related]

  • 3. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL, Luo KX, Feng XR, Fu QX, Hou JL.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 10; 87(26):1840-3. PubMed ID: 17922996
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C.
    Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T.
    Int J Mol Med; 2002 Aug 10; 10(2):201-4. PubMed ID: 12119559
    [Abstract] [Full Text] [Related]

  • 5. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
    Chung YH, Song BC, Lee GC, Shin JW, Ryu SH, Jung SA, Yoo K, Lee HC, Lee YS, Suh DJ.
    Eur J Gastroenterol Hepatol; 2003 May 10; 15(5):489-93. PubMed ID: 12702905
    [Abstract] [Full Text] [Related]

  • 6. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D, Fuchsberger N, Oltman M, Schmeisser H, Kontsek P, Jahnová E, Hajnická V.
    Acta Virol; 2001 May 10; 45(5-6):287-92. PubMed ID: 12083327
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF, Hui CK, Cheng CC, Wu CH, Lai YP, Lai CL.
    Hepatology; 2001 Jul 10; 34(1):139-45. PubMed ID: 11431745
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Efficacy of interferon-alpha therapy for HBeAg-negative chronic hepatitis B and its influencing factors].
    Mao QG, Luo KX, Fu QF, Feng XR, Guo YB, Zhu YF, Peng J, Hou JJ.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct 10; 12(10):582-4. PubMed ID: 15504285
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of Japanese patients with chronic hepatitis B treated with interferon-alpha.
    Truong BX, Seo Y, Kato M, Hamano K, Ninomiya T, Katayama M, Kato H, Yano Y, Hayashi Y, Kasuga M.
    Int J Mol Med; 2005 Aug 10; 16(2):279-84. PubMed ID: 16012762
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H, Ma LX, Xu WS, Zhang HY, Yu LJ, Duan HY.
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar 10; 11(3):173-5. PubMed ID: 12681068
    [Abstract] [Full Text] [Related]

  • 17. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y, Ikeda K, Suzuki F, Suzuki Y, Kobayashi M, Akuta N, Hosaka T, Sezaki H, Yatsuji H, Kawamura Y, Kobayashi M, Kumada H.
    J Med Virol; 2007 Sep 10; 79(9):1286-92. PubMed ID: 17607775
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
    Rico MA, Quiroga JA, Subirá D, Castañón S, Esteban JM, Pardo M, Carreño V.
    Hepatology; 2001 Jan 10; 33(1):295-300. PubMed ID: 11124848
    [Abstract] [Full Text] [Related]

  • 19. Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha.
    van der Eijk AA, Niesters HG, Hansen BE, Heijtink RA, Janssen HL, Schalm SW, de Man RA.
    J Viral Hepat; 2006 Feb 10; 13(2):96-103. PubMed ID: 16436127
    [Abstract] [Full Text] [Related]

  • 20. Interferon therapy of Turkish patients with chronic hepatitis B virus infection.
    Besirbellioglu B, Gul C, Gorenek L, Eyigun CP, Hacibektasoglu A, Van Thiel DH.
    Hepatogastroenterology; 1999 Feb 10; 46(25):387-90. PubMed ID: 10228827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.